Cargando…

Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry

Detalles Bibliográficos
Autores principales: Zu, Shulong, Luo, Dan, Li, Lili, Ye, Qing, Li, Rui-Ting, Wang, Yanan, Gao, Meiling, Yang, Heng, Deng, Yong-Qiang, Cheng, Genhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688909/
https://www.ncbi.nlm.nih.gov/pubmed/34934049
http://dx.doi.org/10.1038/s41392-021-00853-4
_version_ 1784618445402275840
author Zu, Shulong
Luo, Dan
Li, Lili
Ye, Qing
Li, Rui-Ting
Wang, Yanan
Gao, Meiling
Yang, Heng
Deng, Yong-Qiang
Cheng, Genhong
author_facet Zu, Shulong
Luo, Dan
Li, Lili
Ye, Qing
Li, Rui-Ting
Wang, Yanan
Gao, Meiling
Yang, Heng
Deng, Yong-Qiang
Cheng, Genhong
author_sort Zu, Shulong
collection PubMed
description
format Online
Article
Text
id pubmed-8688909
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-86889092021-12-21 Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry Zu, Shulong Luo, Dan Li, Lili Ye, Qing Li, Rui-Ting Wang, Yanan Gao, Meiling Yang, Heng Deng, Yong-Qiang Cheng, Genhong Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-12-21 /pmc/articles/PMC8688909/ /pubmed/34934049 http://dx.doi.org/10.1038/s41392-021-00853-4 Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Zu, Shulong
Luo, Dan
Li, Lili
Ye, Qing
Li, Rui-Ting
Wang, Yanan
Gao, Meiling
Yang, Heng
Deng, Yong-Qiang
Cheng, Genhong
Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
title Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
title_full Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
title_fullStr Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
title_full_unstemmed Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
title_short Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
title_sort tamoxifen and clomiphene inhibit sars-cov-2 infection by suppressing viral entry
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688909/
https://www.ncbi.nlm.nih.gov/pubmed/34934049
http://dx.doi.org/10.1038/s41392-021-00853-4
work_keys_str_mv AT zushulong tamoxifenandclomipheneinhibitsarscov2infectionbysuppressingviralentry
AT luodan tamoxifenandclomipheneinhibitsarscov2infectionbysuppressingviralentry
AT lilili tamoxifenandclomipheneinhibitsarscov2infectionbysuppressingviralentry
AT yeqing tamoxifenandclomipheneinhibitsarscov2infectionbysuppressingviralentry
AT liruiting tamoxifenandclomipheneinhibitsarscov2infectionbysuppressingviralentry
AT wangyanan tamoxifenandclomipheneinhibitsarscov2infectionbysuppressingviralentry
AT gaomeiling tamoxifenandclomipheneinhibitsarscov2infectionbysuppressingviralentry
AT yangheng tamoxifenandclomipheneinhibitsarscov2infectionbysuppressingviralentry
AT dengyongqiang tamoxifenandclomipheneinhibitsarscov2infectionbysuppressingviralentry
AT chenggenhong tamoxifenandclomipheneinhibitsarscov2infectionbysuppressingviralentry